Bluejay Therapeutics
San Mateo, US · Founded 2019 · 3 known investors
Healthcare company acquired by Mirum Pharmaceuticals, a former RiverVest portfolio company.
Founders & leadership
KC
Keting ChuExecutive Officer, Director
DY
Dajun YangDirector
NH
Nancy HongDirector
AL
Alon LazarusDirector
WJ
William J. RutterDirector
TJ
Ting JiaDirector
WC
Wen ChenDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$182MraisedMay 2024 · 19 investors · Other TechnologyRule 506(b)
▶$182MraisedMay 2024 · 19 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Dan EstesDirector
- Pascal KroteeDirector
- Jianqing LiDirector
- Keting ChuExecutive Officer, Director
- Alon LazarusDirector
- Dajun YangDirector
- Offering amount
- $182M
- Amount sold
- $182M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$20.5MraisedAug 2022 · 9 investors · Other TechnologyRule 506(b)
▶$20.5MraisedAug 2022 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Keting ChuExecutive Officer, Director
- Dajun YangDirector
- Nancy HongDirector
- Alon LazarusDirector
- William J. RutterDirector
- Ting JiaDirector
- Wen ChenDirector
- Offering amount
- $41.2M
- Amount sold
- $20.5M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$19.2MraisedJun 2021 · 6 investors · Other TechnologyRule 506(b)
▶$19.2MraisedJun 2021 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Keting ChuExecutive Officer, Director
- Offering amount
- $24.2M
- Amount sold
- $19.2M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.